Valutazione MRD mediante citometria a flusso multiparametrico e NGS nella sperimentazione Forte
fValutazione minima della malattia residua mediante citometria a flusso multiparametrico e sequenziamento di nuova generazione nella sperimentazione Forte per i pazienti affetti da mieloma multiplo di nuova diagnosi
ABOUT FRANCESCA GAY, MD, PhD
Dr. Francesca Gay is a hematologist at the Myeloma Unit, Division of Hematology, Azienda Ospedaliero Università Città della Salute e della Scienza, in Torino, Italy. She completed her medical degree in 2004 and her fellowship in hematology in 2008 at the University of Torino, Italy. She obtained her PhD in Medicine and Experimental Therapy in 2014. She focuses on multiple myeloma and associated disorders, as well as helps the design and development of myeloma clinical trials. Her papers have been published in peer-reviewed journals, and she has been a reviewer for medical journals including Leukemia and Haematologica.